Stem Cell Therapeutics Market - Forecasts to 2025 (Cardiovascular and Circulatory Diseases, Endocrine Diseases, Cancer, Others)

Stem cells are anticipated to demonstrate considerable efficacy in clinical treatment and revenues to manufacturers with suitable products.  Kalorama Information’s Stem Cell Therapeutics Markets is a complete analysis of stem cell drugs now and in development.  The report estimates the opportunity by for novel technologies through an assessment of current products, pipeline, cost trends and regulation.  Bottom-up and Top-Down analysis was used to determine market size and market forecasts.

Over the next several years, as researchers introduce a growing variety of technologies, products and services based upon stem cells, revenues related to stem cell therapies will increase dramatically. New therapeutic applications of stem cells could potentially be realized in all of the following disease segments:

  • Musculoskeletal System 
  • Blood
  • Circulation
  • Endocrine and Metabolic System and Immunity Disorders
  • Occular
  • Gastrointestinal System
  • Connective Tissue
  • Neoplasms
  • CNS
  • Respiratory System
  • Skin 
There are thousands of research projects being worked on that involve stem cell technologies.  Kalorama's report coveres the most promising of these.  . Companies profiled in this report consist of the companies which have registered trials in Phase I through Phase III development.
  • Mesoblast
  • NeoStem
  • Neuralstem
  • Pharmicell
  • Pluristem
  • ReNeuron
  • SanBio
  • StemCells
  • Stemedica Cell
  • Stempeutics
  • Targazyme
  • TiGenix
  • ViaCyte
  • Aastrom Biosciences
  • Advanced Cell Technology
  • Anterogen
  • Antria
  • apceth
  • Arteriocyte
  • Athersys
  • Baxter
  • BioCardia
  • Bioheart
  • BrainStorm Cell
  • Capricor
  • Celgene
  • Cytomedix
  • Cytori
  • Gamida Cell
  • GlaxoSmithKline
  • ISCO
  • Intrexon
  • ISTO
  • Medipost


  • Executive Summary
    • OVERVIEW AND SCOPE OF STUDY
      • Methodology
      • Glossary of Terms
    • SIZE AND GROWTH OF THE MARKET
  • Stem Cells: An Introduction
    • OVERVIEW
    • TYPES OF STEM CELLS
      • Adult Stem Cells
      • Human Embryonic Stem Cells
        • Table Compare and Contrast: Adult vs. Embryonic Stem Cells
    • STEM CELL HARVESTING
      • Harvesting Adult Stem Cells
      • Harvesting Embryonic Stem Cells
    • TRANSPLANTATION OF STEM CELLS
      • Stem Cell Transplant Approaches
      • Autologous Transplantation
      • Allogeneic Transplantation
    • DRUG RESEARCH APPLICATIONS
  • Regulatory Landscape and Research Policy
    • OVERVIEW OF STEM CELL REGULATION
    • THE ETHICAL SIDE OF STEM CELL RESEARCH
    • U.S. REGULATION
      • Fast Track, Breakthrough Therapy, Accelerated Approval and Priority Review
      • United States: State and Federal Initiatives on Embryonic Stem Cells
      • Research Funding
        • Table NIH Funding Trends for Stem Cell Research, Actual FY 2002 - 2013 and Estimated FY 2014 – 2015 ($ in millions)
      • State 'Right to Try' Laws
      • For-Profit Stem Cell Clinics
    • CANADA: STEM CELL RESEARCH GUIDELINES
    • EUROPEAN UNION:MEMBER STATES' REGULATORY POSITION ON HUMAN EMBRYONIC STEM CELL RESEARCH
      • Table European Union Member State Positions on Human Embryonic Stem Cell Research
      • United Kingdom: Initiatives on Embryonic Stem Cells
      • Portugal: Changes in Embryonic Stem Cell Research
    • ASIA:AVIBRANT MARKET FOR STEM CELL RESEARCH
      • China: Stem Cell Research Policies
      • Singapore: An Emerging Market
      • South Korea: An Active Stem Cell Market
    • STEM CELL DEVELOPERS BY COUNTRY OF OPERATION
  • Development Profiles and Analysis
    • OVERVIEW
    • THE EMBRYONIC RESEARCH AND DEVELOPMENT APPROACH
    • STEM CELL TECHNOLOGY PATENTS
    • DEVELOPMENT PROGRAMS
      • Table Phase III Developments in Stem Cell Therapies, Selected Projects
      • Table Phase II Developments in Stem Cell Therapies, Selected Projects
      • Table Phase I Developments in Stem Cell Therapies, Selected Projects
      • Table Preclinical Developments in Stem Cell Therapies, Selected Projects
      • Aastrom Biosciences, Inc.
      • Advanced Cell Technology
      • AlloCure, Inc.
      • Anterogen Co., Ltd.
      • Antria, Inc.
      • apceth GmbH & Co. KG
      • Arteriocyte, Inc.
      • Athersys, Inc.
      • Baxter International
      • BioCardia, Inc.
      • Bioheart, Inc.
      • BrainStorm Cell Therapeutics, Inc.
      • Capricor Therapeutics, Inc.
      • Celgene Cellular Therapeutics
      • Cytomedix, Inc.
      • Cytori Therapeutics, Inc.
      • Gamida Cell Ltd.
      • GlaxoSmithKline plc
      • Histogenics Corporation
      • International Stem Cell Corporation
      • ISTO Technologies, Inc.
      • Medipost Co., Ltd.
      • Mesoblast Ltd.
      • NeoStem, Inc.
      • Neuralstem, Inc.
      • Pharmicell Co., Ltd.
      • Pluristem Therapeutics, Inc.
      • ReNeuron Group plc
      • SanBio, Inc.
      • StemCells, Inc.
      • Stemedica Cell Technologies, Inc.
      • Stempeutics Research Pvt. Ltd.
      • Targazyme, Inc.
      • TiGenix NV
      • ViaCyte, Inc.
    • DEVELOPER MARKET PERFORMANCE: PROJECTED 2025
  • Therapeutic Applications: Current and Potential Stem Cell Segments
    • OVERVIEW
    • DISEASE STATS
      • Table Global Prevalence of Selected Medical Conditions with Potential Stem Cell Therapy Benefits
    • DISEASES OF THE BLOOD AND BLOOD-FORMING ORGANS
      • Aplastic Anemia
      • Sickle-Cell Disease
    • DISEASES OF THE CIRCULATORY SYSTEM
      • Cardiovascular Disease
    • DISEASES OF THE ENDOCRINE AND METABOLIC SYSTEM AND IMMUNITY DISORDERS
      • Diabetes
      • Graft-versus-host Disease
      • Primary Immune Deficiency
      • Systemic Lupus Erythematosus
    • DISEASES OF THE EYE
      • Macular Degeneration
      • Diabetic Retinopathy
      • Blindness
    • DISEASES OF THE GASTROINTESTINAL SYSTEM
      • Intestinal Diseases
      • Liver Failure
    • DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DISORDERS
      • Arthritis
      • Orthopedic Surgery
      • Osteoporosis
    • NEOPLASMS
      • Bladder Cancer
      • Brain Cancer
      • Breast Cancer
      • Cervical Cancer
      • Colorectal Cancer
      • Esophageal Cancer
      • Kidney
      • Leukemia
        • Table Leukemia Overview by Type
      • Liver Cancer
      • Lung Cancer
        • Table Types of Primary Lung Cancer
      • Lymphoma
        • Table Classification of Non-Hodgkin's Lymphomas
      • Melanoma
        • Table Malignant Conditions of the Skin
      • Multiple Myeloma
      • Ovarian Cancer
      • Pancreatic Cancer
      • Prostate Cancer
      • Stomach Cancer
    • DISEASES OF THE NERVOUS SYSTEM
      • Alzheimer's Disease
      • Amyotrophic Lateral Sclerosis
      • Multiple Sclerosis
      • Parkinson's Disease
    • DISEASES OF THE RESPIRATORY SYSTEM
      • Asthma
      • COPD
    • DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUES
      • Chronic Skin Wounds
      • Burn Skin Wounds
  • Stem Cell Market Summary and Outlook
    • OVERVIEW
    • STEM CELL FORECAST ANALYSIS
    • STEM CELL MARKET ANALYSIS BY DISEASE CLASSIFICATION
    • DISEASE SUMMARY
      • Table Population Affected by Select Diseases and Conditions by Type
    • STEM CELL OUTLOOK IN CIRCULATORY / CARDIOVASCULAR DISEASES
      • Stem Cell Outlook in Atherosclerosis
      • Stem Cell Outlook in Heart Failure
      • Stem Cell Outlook in Critical Limb Ischemia
      • Stem Cell Outlook in Myocardial Infarction
    • STEM CELL OUTLOOK IN METABOLIC / ENDOCRINE DISEASES AND IMMUNOLOGY DISORDERS
      • Stem Cell Market Outlook: Diabetes
        • Table World Diabetes Prevalence by Country
      • Stem Cell Outlook in Graft-versus-host Disease
      • Stem Cell Outlook in Systemic Lupus Erythematosus
    • STEM CELL OUTLOOK IN DIGESTIVE DISORDERS
      • Stem Cell Outlook in Crohn's Disease
      • Stem Cell Outlook in Liver Failure
    • STEM CELL OUTLOOK IN MUSCULOSKELETAL DISEASES
      • Stem Cell Outlook in Osteoarthritis
      • Stem Cell Outlook in Osteoporosis
      • Stem Cell Outlook in Orthopedic Trauma
      • Stem Cell Outlook in Rheumatoid Arthritis
    • STEM CELL OUTLOOK IN CANCER
      • Stem Cell Outlook by Cancer Type
        • Table World Cancer Incidence by Selected Types of Cancer, 2012 and 2025, All Races, All Ages, Both Genders
    • STEM CELL OUTLOOK IN NERVOUS SYSTEM DISORDERS
      • Stem Cell Outlook in Alzheimer's Disease
      • Stem Cell Outlook in Amyotrophic Lateral Sclerosis
      • Stem Cell Outlook in Multiple Sclerosis
        • Table Estimated World Prevalence of Multiple Sclerosis by Selected Countries
      • Stem Cell Outlook in Parkinson's Disease
    • STEM CELL OUTLOOK IN SKIN DISORDERS
      • Stem Cell Outlook in Wound Healing
      • Stem Cell Outlook in Wrinkles and Aging Skin Conditions
    • STEM CELLS IN OTHER AREAS OF FOCUS
      • Asthma Outlook
      • Chronic Obstructive Pulmonary Disease Outlook
      • Incontinence Outlook
      • Macular Degeneration Outlook
      • Male Infertility Outlook
      • Tooth Regeneration Outlook
    • CONCLUSION
  • Industry Participants

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook